We are live on
!
Find out more
MLL
Moody Lynn & Lieberson Portfolio holdings
AUM
$1.9B
1-Year Est. Return
27.82%
This Fund
S&P 500
This Quarter
Est. Return
-3.22%
1 Year Est. Return
+27.82%
3 Year Est. Return
+128.03%
5 Year Est. Return
+198.12%
10 Year Est. Return
+974.77%
AUM
$1.04B
AUM Growth
-$74.8M
(-6.7%)
Cap. Flow
-$1.02B
Cap. Flow
% of AUM
-98.71%
Top 10 Holdings %
Top 10 Hldgs %
30.61%
Holding
232
New
13
Increased
34
Reduced
92
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uber
UBER
|
+$14.6M |
| 2 |
Atlassian
TEAM
|
+$9.28M |
| 3 |
NextEra Energy
NEE
|
+$8.3M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$8.2M |
| 5 |
Agilent Technologies
A
|
+$4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$895M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$113M |
| 3 |
NVIDIA
NVDA
|
+$5.81M |
| 4 |
AbbVie
ABBV
|
+$5.65M |
| 5 |
AstraZeneca
AZN
|
+$5.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.88% |
| 2 | Healthcare | 21.94% |
| 3 | Financials | 14.33% |
| 4 | Industrials | 11.15% |
| 5 | Consumer Staples | 6.69% |
Similar funds
EP
SIC
DCP
OPCM
FTCM
RCA
IAN
VC
Moody Lynn & Lieberson's Q3 2022 Portfolio in Review
As of Q3 2022, Moody Lynn & Lieberson held 232 positions worth $1.04B, down 6.7% from $1.11B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Moody Lynn & Lieberson withdrew a net $1.02B in Q3 2022, closing 16 positions and reducing 92 holdings. Its most notable exit was AstraZeneca, an estimated $5.63M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Moody Lynn & Lieberson opened a new position in Uber worth $14M.
- Moody Lynn & Lieberson's largest Q3 2022 buy was Uber: 529,300 shares worth $14M.
- Moody Lynn & Lieberson added most to Atlassian in Q3 2022, an estimated $9.28M increase.
- Moody Lynn & Lieberson's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $895M.
- Moody Lynn & Lieberson fully exited AstraZeneca in Q3 2022, selling an estimated $5.63M.
- Moody Lynn & Lieberson's ten largest holdings make up 31% of its $1.04B portfolio in Q3 2022.
- Moody Lynn & Lieberson opened 13 new positions and closed 16 in Q3 2022.
- Moody Lynn & Lieberson's portfolio value fell 6.7% quarter-over-quarter to $1.04B.
Based on Moody Lynn & Lieberson's 13F filing for Q3 2022, filed 26 Oct 2022.